日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder

为期六周的开放标签口服氯胺酮治疗难治性抑郁症、创伤后应激障碍或强迫症患者

Beaglehole, Ben; Glue, Paul; Neehoff, Shona; Shadli, Shabah; McNaughton, Neil; Kimber, Bridget; Muirhead, Chrissie; de Bie, Aroha; Day-Brown, Rachel; Hughes-Medlicott, Natalie J

Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study

氯胺酮治疗难治性强迫症:双盲活性对照交叉研究

Beaglehole, Ben; Glue, Paul; Neehoff, Shona; Shadli, Shabah; McNaughton, Neil; Kimber, Bridget; Muirhead, Chrissie; Bie, Aroha de; Day-Brown, Rachel; Hughes-Medlicott, Natalie J

Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study

氯胺酮治疗难治性创伤后应激障碍:双盲、活性对照、随机交叉研究

Beaglehole, Ben; Glue, Paul; Neehoff, Shona; Shadli, Shabah; McNaughton, Neil; Kimber, Bridget; Muirhead, Chrissie; de Bie, Aroha; Day-Brown, Rachel; Hughes-Medlicott, Natalie J

Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study

氯胺酮治疗难治性重度抑郁症:双盲活性对照交叉研究

Glue, Paul; Neehoff, Shona; Beaglehole, Ben; Shadli, Shabah; McNaughton, Neil; Hughes-Medlicott, Natalie J

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

缓释氯胺酮片剂治疗难治性抑郁症和焦虑症患者的安全性和有效性:开放标签试点研究

Glue, Paul; Medlicott, Natalie J; Neehoff, Shona; Surman, Peter; Lam, Fred; Hung, Noelyn; Hung, Cheung-Tak

Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety

氯胺酮治疗难治性广泛性焦虑症和社交焦虑症期间对脑电图的影响

Shadli, Shabah Mohammad; Kawe, Tame; Martin, Daniel; McNaughton, Neil; Neehoff, Shona; Glue, Paul